Page 28 - Ppd Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Here's what to look for and what to steer clear of.

Colony Bankorp, Inc. (NASDAQ: CBAN) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Colony Bankorp, Inc. (NASDAQ: CBAN ) in connection with the proposed merger of the company with SouthCrest Financial Group.  Under the terms of the merger agreement, each SouthCrest shareholder will have the right to elect to receive either $10.45 in cash or 0.7318 shares of CBAN common stock in exchange for each share of SouthCrest common stock that they own, subject to proration.  If you own CBAN shares and wish to discuss this in...

Thermo Fisher Drops Despite Earnings Beat Shares of Thermo Fisher dropped Thursday despite more than doubling adjusted first-quarter earnings on a 59% increase in revenue. Author: Shares of Thermo Fisher Scientific  ( TMO) - Get Report were dropping Thursday even after the life sciences company more than doubled adjusted first-quarter earnings on a 59% increase in revenue. Shares of the Waltham, Mass., company fell 3.5% to $469 at last check. Thermo Fisher reported adjusted net income of $7.21 a share, compared to $2.94 a share in the year-ago period. Revenue rose 59% to $9.9 billion from...

PPD, Inc.: PPD to Expand GMP Lab in Ireland to Enhance Biopharmaceutical Testing Capabilities Adding cell and gene therapy capabilities to support growing customer need PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, is expanding its Athlone, Ireland, GMP (good manufacturing practices) laboratory, significantly increasing the size of its current facility and adding cell and gene therapy testing to the operation's portfolio of services. The expansion enhances PPD's ability to deliver global scientific and technical expertise to meet growing customer demand in Europe, ...

WILMINGTON, N.C.--(BUSINESS WIRE)--Apr 28, 2021-- PPD, Inc. (Nasdaq: PPD ), a leading global contract research organization, is expanding its Athlone, Ireland, GMP (good manufacturing practices) laboratory, significantly increasing the size of its current facility and adding cell and gene therapy testing to the operation’s portfolio of services. The expansion enhances PPD’s ability to deliver global scientific and technical expertise to meet growing customer demand in Europe, the Middle East and Africa, and the Asia-Pacific region. By offering these services at its Athlone operation...